The Verona Pharma plc (VRNA) shares are trading at higher $10.20 and the avg recommendation for the stock is Strong Buy.
To add more color to this target, the company’s high over the last year is $12.89 and the low is $2.01. Over the last 52 weeks, VRNA is down -20.87% while the S&P 500 is up 0.29%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, VRNA reported a profit of $67000.0. Verona Pharma plc also saw revenues increase to $14.31 million. In addition, VRNA has free cash flow of -$13.0 million as of 03-2020. The company’s EBITDA came in at -$14.12 million which compares well with its peers.
Find out when VRNA reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. VRNA has a short ratio of 0.32 and outstanding shares of 13.32M.
VRNA has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 13.7 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -2.34. Verona Pharma plc VRNA also noted assets of $45.94 million at the end of the last quarter. Investors should also keep an eye on sector updates as VRNA has historically followed its peers on positive news.
All told, Verona Pharma plc VRNA has strung together solid data and demonstrated underlying fundamentals. At its current valuation, VRNA represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Verona Pharma plc VRNA is now commanding a market cap of 135.83M and a float of 5.85M. VRNA is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of VRNA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in VRNA, either long or short, and we have not been compensated for this article.